Interdisciplinary approach to the management of patients with uterine cancer progression-Reference-Cited by-同舟云学术

Interdisciplinary approach to the management of patients with uterine cancer progression

Published:2022-05-08 Issue:1 Volume:18 Page:87-96
ISSN:1999-8627
Container-title:Tumors of female reproductive system
language:
Short-container-title:Opuholi ženskoj reproduktivnoj sistemy

Author:

Morkhov K. Yu.¹^ORCID,Kreinina Yu. M.²^ORCID,Pokataev I. A.³^ORCID,Nechushkina V. M.⁴^ORCID

Affiliation:

1. Scientific Research Institute of Оncogynecology and Mammology, National Medical Research Center for Obstetrics, Gynecology and Perinatology named after V. I. Kulakov, Ministry of Health of Russia

2. Russian Scientific Center of Roentgenoradiology, Ministry of Health of Russia; First Moscow State Medical University named after I.M. Sechenov (Sechenov University), Ministry of Health of Russia

3. City Clinical Oncology Hospital No. 1, Moscow Health Department

4. Privolzhsky Research Medical University, Ministry of Health of Russia

Abstract

Endometrial cancer is the most common gynecologic malignancy in Russia. Surgery and/or chemoand radiotherapy remain standard clinical approach. This review describes multidisciplinary approach as the state of the art in the disease management. We notice the importance of molecular assessment for driving the clinic decision and newly emerging medical treatments, such as immunotherapy and antiangiogenic tyrosine kinase inhibitors and immunotherapy combinations.

Publisher

Publishing House ABV Press

Subject

Pharmacology (medical),Obstetrics and Gynecology,Radiology, Nuclear Medicine and imaging,Oncology,Surgery

Reference81 articles.

1. Lortet-Tieulent J., Ferlay J., Bray F. et al. International patterns and trends in endometrial cancer incidence, 1978–2013. J Natl Cancer Inst 2018;110(4):354–361. DOI: 10.1093/jnci/djx214.

2. Malignant tumors (n Russia in 2019 (morbidity and mortality). Eds.: А.D. Kaprin, V.V. Starinskiy, G.V. Shakhzadova. Moscow: MNIOI im. P.A. Gertsena – filial FGBU “NMIRTS” Minzdrava Rossii, 2020. 252 p. (In Russ.).

3. Creutzberg C.L., Van Putten W.L., Koper P.C. et al. Survival after relapse in patients with endometrial cancer: results from a randomized trial. Gynecol Oncol2003;89(2):201–9.

4. Creutzberg C.L., Nout R.A., Lybeert M.L. et al. Fifteen-year radiotherapy outcomes of the randomized PORTEC-1 trial for endometrial carcinoma. Int J Radiat Oncol Biol Phys 2011;81(4):e631–8. DOI: 10.1016/j.ijrobp.2011.04.013.

5. Yechieli R., Robbins J.R., Schultz D. et al. Vaginal recurrence more than 17 years after hysterectomy and adjuvant treatment for uterine carcinoma with successful salvage brachytherapy: A case report. Case Rep Oncol 2011;4(1):242–5. DOI:10.1159/000328076.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Age-related characteristics of the content and activity of certain components of the blood fibrinolytic system in cases of uterine cancer;Сибирский научный медицинский журнал;2024-08-30